{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:56:38Z","timestamp":1787637398995,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["471461\/2011-3"],"award-info":[{"award-number":["471461\/2011-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006181","name":"FAPESB","doi-asserted-by":"publisher","award":["6596"],"award-info":[{"award-number":["6596"]}],"id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["PPM-00342-16"],"award-info":[{"award-number":["PPM-00342-16"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","award":["PVE A118\/2013"],"award-info":[{"award-number":["PVE A118\/2013"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ejmech.2017.09.047","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T19:31:02Z","timestamp":1506108662000},"page":"346-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8275-3337","authenticated-orcid":false,"given":"Gevanio Bezerra","family":"de Oliveira Filho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Ver\u00edssimo de Oliveira","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Wanderlan Pontes","family":"Esp\u00edndola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayane Albuquerque","family":"Oliveira e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Salgado","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyanne Lacerda","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e2mela Silva dos","family":"Anjos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuelle de Souza","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ssio Santana","family":"Meira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Rodrigo Magalhaes","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Botelho Pereira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina Lima","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.09.047_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2015.12.017","article-title":"Current drug therapy and pharmaceutical challenges for Chagas disease","volume":"156","author":"Bermudez","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2017.09.047_bib2","series-title":"About Chagas Disease \u2013 DNDi","author":"DNDI","year":"2017"},{"key":"10.1016\/j.ejmech.2017.09.047_bib3","series-title":"WHO | Chagas Disease (American Trypanosomiasis)","author":"WHO","year":"2014"},{"key":"10.1016\/j.ejmech.2017.09.047_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.eimc.2015.12.008","article-title":"Actualizaci\u00f3n en enfermedad de Chagas","volume":"34","author":"Molina","year":"2016","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.ejmech.2017.09.047_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pt.2003.09.001","article-title":"Specific chemotherapy of Chagas disease: controversies and advances","volume":"19","author":"Urbina","year":"2003","journal-title":"Trends Parasitol."},{"issue":"Suppl","key":"10.1016\/j.ejmech.2017.09.047_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S0074-02762009000900034","article-title":"Two approaches to discovering and developing new drugs for Chagas disease","volume":"104","author":"McKerrow","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2017.09.047_bib7","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/nature09224","article-title":"Chagas disease: pushing through the pipeline","volume":"465","author":"Clayton","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2017.09.047_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2017.09.047_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2017.09.047_bib10","doi-asserted-by":"crossref","first-page":"e1004114","DOI":"10.1371\/journal.ppat.1004114","article-title":"Squalene synthase as a target for Chagas disease therapeutics","volume":"10","author":"Shang","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2017.09.047_bib11","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1016\/j.bmcl.2015.06.066","article-title":"Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' disease","volume":"25","author":"Neitz","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.09.047_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijantimicag.2016.02.018","article-title":"Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease","volume":"48","author":"Sbaraglini","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2017.09.047_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1074-5521(00)00018-1","article-title":"Aryl ureas represent a new class of anti-trypanosomal agents","volume":"7","author":"Du","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2017.09.047_bib14","doi-asserted-by":"crossref","first-page":"e2370","DOI":"10.1371\/journal.pntd.0002370","article-title":"Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in\u00a0vitro assay","volume":"7","author":"Wiggers","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2017.09.047_bib15","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.bmc.2009.07.068","article-title":"Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents","volume":"17","author":"dos Santos Filho","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bmc.2008.11.065","article-title":"Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates","volume":"17","author":"Romeiro","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib17","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.3390\/molecules18066366","article-title":"Design, synthesis and trypanocidal evaluation of novel 1,2,4-Triazoles-3-thiones derived from natural piperine","volume":"18","author":"Franklim","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.09.047_bib18","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1021\/ja710254m","article-title":"Identification of a new class of nonpeptidic inhibitors of cruzain","volume":"130","author":"Brak","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.09.047_bib19","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/jm901633v","article-title":"Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy","volume":"53","author":"Brak","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib20","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/jm010459j","article-title":"Synthesis and Structure\u2212Activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain","volume":"45","author":"Du","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib21","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/jm030549j","article-title":"Synthesis and Structure\u2212Activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against plasmodium falciparum, trypanosoma brucei, and trypanosoma cruzi","volume":"47","author":"Greenbaum","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib22","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/j.bmcl.2006.05.041","article-title":"Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease","volume":"16","author":"Siles","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.09.047_bib23","first-page":"1045","article-title":"Molecular features for antitrypanosomal activity of thiosemicarbazones revealed by OPS-PLS QSAR studies","volume":"8","author":"Beatriz Huaman Lozano","year":"2012","journal-title":"Med. Chem. Los. Angeles)"},{"key":"10.1016\/j.ejmech.2017.09.047_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejmech.2014.02.001","article-title":"Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death","volume":"75","author":"Magalhaes Moreira","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejmech.2015.06.048","article-title":"Synthesis and structure\u2013activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain","volume":"101","author":"Esp\u00edndola","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cmdc.200700022","article-title":"Synthesis, cruzain docking, and in\u00a0vitro studies of aryl-4-oxothiazolylhydrazones AgainstTrypanosoma cruzi","volume":"2","author":"Leite","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2017.09.047_bib27","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.bmc.2010.09.056","article-title":"Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents","volume":"18","author":"Zaldini Hernandes","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib28","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1021\/jm301518v","article-title":"Structural investigation of anti- trypanosoma cruzi 2-Iminothiazolidin-4-ones allows the identification of agents with efficacy in infected mice","volume":"55","author":"Moreira","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2014.08.012","article-title":"2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation","volume":"86","author":"de O. Cardoso","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejmech.2016.05.050","article-title":"New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi","volume":"121","author":"de Moraes Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2016.01.010","article-title":"Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi","volume":"111","author":"de M. Gomes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib32","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1016\/j.bmc.2015.10.048","article-title":"Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi","volume":"23","author":"de Oliveira Filho","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/81100793","article-title":"The chemistry of?-Haloketones and their utility in heterocyclic synthesis","volume":"8","author":"Erian","year":"2003","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.09.047_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ultsonch.2011.10.017","article-title":"Efficient one-pot three-component synthesis of N-(4-arylthiazol-2-yl) hydrazones in water under ultrasound irradiation","volume":"19","author":"Zhang","year":"2012","journal-title":"Ultrason. Sonochem"},{"key":"10.1016\/j.ejmech.2017.09.047_bib35","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/j.bmc.2006.01.043","article-title":"Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones","volume":"14","author":"Vicini","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1747-0285.2010.01071.x","article-title":"Synthesis of 2-hydrazolyl-4-thiazolidinones based on multicomponent reactions and biological evaluation against Trypanosoma Cruzi","volume":"77","author":"Pizzo","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2017.09.047_bib37","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.bmc.2006.01.034","article-title":"Synthesis, docking, and in\u00a0vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against Trypanosoma cruzi","volume":"14","author":"Leite","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cmdc.201300354","article-title":"Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity","volume":"9","author":"Moreira","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2017.09.047_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejmech.2012.07.013","article-title":"Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents","volume":"55","author":"Caputto","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2017.02.026","article-title":"Desing and synthesis of potent anti - Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death","volume":"130","author":"da Silva","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib41","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/jm9009229","article-title":"Divergent modes of enzyme inhibition in a homologous structure-activity series","volume":"52","author":"Ferreira","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib42","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1016\/j.bmc.2012.08.047","article-title":"Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice","volume":"20","author":"dos Santos Filho","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib43","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1128\/AAC.00323-10","article-title":"In\u00a0vitro and in\u00a0vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease","volume":"54","author":"Matsuo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.09.047_bib44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.actatropica.2007.12.005","article-title":"Anti-malarial efficacy of pyronaridine and artesunate in combination in\u00a0vitro and in\u00a0vivo","volume":"105","author":"Vivas","year":"2008","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2017.09.047_bib45","doi-asserted-by":"crossref","first-page":"e2367","DOI":"10.1371\/journal.pntd.0002367","article-title":"Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments","volume":"7","author":"de F. Diniz","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2017.09.047_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.ejmech.2017.09.047_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2017.09.047_bib48","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/tx200211v","article-title":"Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety","volume":"24","author":"Meanwell","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2017.09.047_bib49","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.047_bib50","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/AAC.04601-14","article-title":"Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and schistosoma mansoni cathepsin B1","volume":"59","author":"Fonseca","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.09.047_bib51","doi-asserted-by":"crossref","first-page":"e0003493","DOI":"10.1371\/journal.pntd.0003493","article-title":"Automated high-content assay for compounds selectively toxic to trypanosoma cruzi in a myoblastic cell line","volume":"9","author":"Alonso-Padilla","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2017.09.047_bib52","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in\u00a0vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.09.047_bib53","unstructured":"Z. BRENER, Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi., Rev. Inst. Med. Trop. Sao Paulo. 4 (n.d.) 389\u2013396."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417307626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417307626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T06:57:54Z","timestamp":1535353074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417307626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":53,"alternative-id":["S0223523417307626"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.047","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}